Healthcare Triangle, Inc. (HCTI) has entered into definitive agreements for the planned separation and spin-off of its wholly-owned subsidiary, Teyame AI Holdings, Inc. The transaction will involve distributing a minority stake in Teyame to HCTI shareholders on a pro-rata basis. Following the spin-off, HCTI will remain the majority shareholder, and Teyame is intended to operate as a separate publicly traded company listed on Nasdaq.
Key Details
- Transaction Structure: On September 2, 2026, HCTI entered into a Separation and Distribution Agreement and a Transition Services Agreement with Teyame to facilitate the spin-off.
- Distribution to Shareholders: HCTI will distribute a minority interest of Teyame's outstanding common stock to HCTI's common stockholders. HCTI will retain a majority ownership interest in Teyame after the distribution.
- Future Operations: Teyame, which holds the recently acquired companies Teyamé 360, S.L. and Datono Mediación S.L., will operate as a separate public company. Conditions for the spin-off include the effectiveness of Teyame's Form 10 registration statement and approval for listing its common stock on The Nasdaq Stock Market.
- Transition Services: HCTI will provide Teyame with transitional services, including accounting, administrative, legal, HR, and IT support to ensure operational continuity post-separation.
- Tax Implications: The spin-off is currently expected to be a taxable distribution for U.S. federal income tax purposes to both HCTI and its shareholders.